CSNpharm
CSNpharm
Isotaxiresinol, a natural product isolated and purified from the branch of Taxus wallichiana, may be useful for treatment of postmenopausal osteoporosis, especially for prevention of bone fracture induced by estrogen deficiency, and prevents d-GalN/LPS-induced hepatic injury by inhibiting hepatocyte apoptosis through the blocking of TNF-alpha and IFN-gamma production by activated macrophages and direct inhibition of […]
More Information
Supplier Page
CSNpharm
Isotaxiresinol, a natural product isolated and purified from the branch of Taxus wallichiana, may be useful for treatment of postmenopausal osteoporosis, especially for prevention of bone fracture induced by estrogen deficiency, and prevents d-GalN/LPS-induced hepatic injury by inhibiting hepatocyte apoptosis through the blocking of TNF-alpha and IFN-gamma production by activated macrophages and direct inhibition of […]
More Information
Supplier Page
CSNpharm
Isotetrandrine, a natural product isolated and purified from the roots of Stephania tetrandra S.Moore, dose-dependently suppresses the severity of LPS-induced ALI by inactivation of MAPK and NF-κB, which may involve the inhibition of tissue oxidative injury and pulmonary inflammatory process.
More Information
Supplier Page
CSNpharm
Isotetrandrine, a natural product isolated and purified from the roots of Stephania tetrandra S.Moore, dose-dependently suppresses the severity of LPS-induced ALI by inactivation of MAPK and NF-κB, which may involve the inhibition of tissue oxidative injury and pulmonary inflammatory process.
More Information
Supplier Page
CSNpharm
Isothymusin, a natural product isolated and purified from the herbs of Limnophila geoffrayi, exhibits inhibition activity against Mycobacterium tuberculosis (MIC=200 mg/mL) and antioxidant activity against the radical scavenging ability of DPPH (IC50=7.7 mg/mL).
More Information
Supplier Page
CSNpharm
Isothymusin, a natural product isolated and purified from the herbs of Limnophila geoffrayi, exhibits inhibition activity against Mycobacterium tuberculosis (MIC=200 mg/mL) and antioxidant activity against the radical scavenging ability of DPPH (IC50=7.7 mg/mL).
More Information
Supplier Page
CSNpharm
Isotretinoin, an analogue of retinoic acid, is an agonist of retinoic acid receptors that is used for the treatment of severe acne.
More Information
Supplier Page
CSNpharm
Isotretinoin, an analogue of retinoic acid, is an agonist of retinoic acid receptors that is used for the treatment of severe acne.
More Information
Supplier Page
CSNpharm
Isovanicaline, a natural product isolated and purified from the barks of Pinus yunnanensis, is a selective inhibitor of aldehyde oxidase, is metabolized by aldehyde dehydrogenase into isovanillic acid ,and the LD50 (rat, ipr) is 1276 mg/kg.
More Information
Supplier Page
CSNpharm
Isovanicaline, a natural product isolated and purified from the barks of Pinus yunnanensis, is a selective inhibitor of aldehyde oxidase, is metabolized by aldehyde dehydrogenase into isovanillic acid ,and the LD50 (rat, ipr) is 1276 mg/kg.
More Information
Supplier Page
CSNpharm
CSNpharm
Isovitexin, a natural product isolated and purified from the seeds of Vitex trifolia L., exhibits a potential antioxidant activity, shows a strong antihyperglycemic action, and inhibits α-glucosidase in vivo.
More Information
Supplier Page
CSNpharm
Isovitexin, a natural product isolated and purified from the seeds of Vitex trifolia L., exhibits a potential antioxidant activity, shows a strong antihyperglycemic action, and inhibits α-glucosidase in vivo.
More Information
Supplier Page
CSNpharm
Isovitexin, a natural product isolated and purified from the seeds of Vitex trifolia L., exhibits a potential antioxidant activity, shows a strong antihyperglycemic action, and inhibits α-glucosidase in vivo.
More Information
Supplier Page
CSNpharm
Isovitexin, a natural product isolated and purified from the seeds of Vitex trifolia L., exhibits a potential antioxidant activity, shows a strong antihyperglycemic action, and inhibits α-glucosidase in vivo.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Itopride HCl is a D2 antagonist and an AChE inhibitor with an IC50 value of 2.04±0.27 μM. It is a prokinetic benzamide derivative unlike domperidone.
More Information
Supplier Page
CSNpharm
Itopride HCl is a D2 antagonist and an AChE inhibitor with an IC50 value of 2.04±0.27 μM. It is a prokinetic benzamide derivative unlike domperidone.
More Information
Supplier Page
CSNpharm
Itopride HCl is a D2 antagonist and an AChE inhibitor with an IC50 value of 2.04±0.27 μM. It is a prokinetic benzamide derivative unlike domperidone.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
ITSA-1
100mg
| ≥99%
CSNpharm
ITX3
50mg
| ≥98%
CSNpharm
ITX3 is a specific and nontoxic inhibitor of the TrioN (N-terminal GEF domain of the multidomain Trio protein) with IC50 of 76 μM and inhibits TrioN-stimulated RhoG exchange in vitro.
More Information
Supplier Page
ITX3
25mg
| ≥98%
CSNpharm
ITX3 is a specific and nontoxic inhibitor of the TrioN (N-terminal GEF domain of the multidomain Trio protein) with IC50 of 76 μM and inhibits TrioN-stimulated RhoG exchange in vitro.
More Information
Supplier Page
ITX3
5mg
| ≥98%
CSNpharm
ITX3 is a specific and nontoxic inhibitor of the TrioN (N-terminal GEF domain of the multidomain Trio protein) with IC50 of 76 μM and inhibits TrioN-stimulated RhoG exchange in vitro.
More Information
Supplier Page
ITX3
10mg
| ≥98%
CSNpharm
ITX3 is a specific and nontoxic inhibitor of the TrioN (N-terminal GEF domain of the multidomain Trio protein) with IC50 of 76 μM and inhibits TrioN-stimulated RhoG exchange in vitro.
More Information
Supplier Page
CSNpharm
Ivabradine HCl is the first selective sinus node I(f) channel, used for the symptomatic management of stable heart-related chest pain and heart failure not fully managed by β blockers.
More Information
Supplier Page
CSNpharm
Ivabradine HCl is the first selective sinus node I(f) channel, used for the symptomatic management of stable heart-related chest pain and heart failure not fully managed by β blockers.
More Information
Supplier Page
CSNpharm
Ivabradine HCl is the first selective sinus node I(f) channel, used for the symptomatic management of stable heart-related chest pain and heart failure not fully managed by β blockers.
More Information
Supplier Page
CSNpharm
Ivabradine HCl is the first selective sinus node I(f) channel, used for the symptomatic management of stable heart-related chest pain and heart failure not fully managed by β blockers.
More Information
Supplier Page
IWP 4
25mg
| ≥99%
CSNpharm
IWP 4
5mg
| ≥99%
CSNpharm
IWP 4
1mg
| ≥99%
CSNpharm
IWP 4
10mg
| ≥99%
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Ixabepilone is a microtubule inhibitor working by binding to tubulin and promoting tubulin polymerization and microtubule stabilization.
More Information
Supplier Page